Potent NKT cell ligands overcome SARS-CoV-2 immune evasion to mitigate viral pathogenesis in mouse models
Authors: Hongjia Lu, Zhewei Liu, Xiangxue Deng, Siyang Chen, Ruiting Zhou, Rongqi Zhao, Ramya Parandaman, Amarjot Thind, Jill Henley, Lei Tian, Jianhua Yu, Lucio Comai, Pinghui Feng, Weiming Yuan
Journal: PLOS Pathogens
Accepted: 2023-02-24T00:00:00Z


One of the major pathogenesis mechanisms of SARS-CoV-2 is its potent suppression of innate immunity, including blocking the production of type I interferons. However, it is unknown whether and how the virus interacts with different innate-like T cells, including NKT, MAIT and γδ T cells. Here we reported that upon SARS-CoV-2 infection, invariant NKT (iNKT) cells rapidly trafficked to infected lung tissues from the periphery. We discovered that the envelope (E) protein of SARS-CoV-2 efficiently down-regulated the cell surface expression of the antigen-presenting molecule, CD1d, to suppress the function of iNKT cells. E protein is a small membrane protein and a viroporin that plays important roles in virion packaging and envelopment during viral morphogenesis. We showed that the transmembrane domain of E protein was responsible for suppressing CD1d expression by specifically reducing the level of mature, post-ER forms of CD1d, suggesting that it suppressed the trafficking of CD1d proteins and led to their degradation. Point mutations demonstrated that the putative ion channel function was required for suppression of CD1d expression and inhibition of the ion channel function using small chemicals rescued the CD1d expression. Importantly, we discovered that among seven human coronaviruses, only E proteins from highly pathogenic coronaviruses including SARS-CoV-2, SARS-CoV and MERS suppressed CD1d expression, whereas the E proteins of human common cold coronaviruses, HCoV-OC43, HCoV-229E, HCoV-NL63 and HCoV-HKU1, did not. These results suggested that E protein-mediated evasion of NKT cell function was likely an important pathogenesis factor, enhancing the virulence of these highly pathogenic coronaviruses. Remarkably, activation of iNKT cells with their glycolipid ligands, both prophylactically and therapeutically, overcame the putative viral immune evasion, significantly mitigated viral pathogenesis and improved host survival in mice. Our results suggested a novel NKT cell-based anti-SARS-CoV-2 therapeutic approach.
Author summary: The ongoing COVID-19 pandemic is the most severe public health crisis in recent history. Even with efficacious vaccines, it is imperative to better understand the mechanism of viral pathogenesis particularly how SARS-CoV-2 suppresses human innate immunity in order to develop more powerful and effective treatments, not only for the current pandemic, but also for the potential re-emergence of new variants. Here we reported the first in-depth characterization of SARS-CoV-2 interaction with the important arm of innate immunity, CD1d-restricted natural killer T (NKT) cells. We discovered NKT cells were rapidly recruited to lungs post infection. The virus employed its envelope protein to suppress the expression of the key antigen-presenting molecule, CD1d, and inhibited the activation of innate NKT cells. Remarkably, we discovered that this immune evasion was unique to highly pathogenic coronaviruses and absent from common cold coronaviruses, suggesting that this new immune evasion mechanism was an important virulence factor. More importantly, we demonstrated that activation of invariant NKT cells significantly overcame the viral immune evasion and improved the host survival.